Table 6.

Probability Tradeoff Results, Stratified by Treatment Cohort

	Patients Who Received ADT (n = 20)	Patients Who Did Not Receive ADT (n = 20)	P Value
Median [IQR] increase in survival	5% [3–13%]	15% [13–19%]	<0.001
Mean [SD] increase in survival	8% [7%]	16% (5%)
<5% absolute increase in survival	12 (60%)	0 (0%)	<0.001
6–10% absolute increase in survival	3 (15%)	4 (20%)
11–15% absolute increase in survival	2 (10%	10 (50%)
16–20% absolute increase in survival	3 (15%)	2 (10%)
>25% absolute increase in survival	0 (0%)	4 (20%)